FENTORA 400 MCG — DIN 02408023
FENTANYL (FENTANYL CITRATE) : 400 MCG · TEVA CANADA LIMITED · TABLET (EFFERVESCENT) · wholesale supply in Canada
Health Canada status: MARKETED
What is FENTORA?
FENTORA 400 MCG contains FENTANYL (FENTANYL CITRATE) : 400 MCG. It is listed in the Health Canada Drug Product Database under DIN 02408023, held by TEVA CANADA LIMITED, supplied as TABLET (EFFERVESCENT) for SUBLINGUAL ; BUCCAL administration. Health Canada currently lists it as marketed, status dated 22-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FENTORA used for?
FENTORA (fentanyl buccal/sublingual effervescent tablets) is indicated only for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to continuous opioid therapy for their persistent baseline cancer pain.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Fentanyl cost around the world?
Fentanyl is listed on 17 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Czechia | max producer price (ex-factory) | 17 | 104 | CZK███.██ |
| Sweden | AIP (pharmacy purchase price) | 10 | 95 | SEK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 38 | 58 | EUR███.██ |
| United States | acquisition | 10 | 56 | USD███.██ |
| Australia | ex-manufacturer | 5 | 45 | AUD███.██ |
| Romania | max producer price | 26 | 45 | RON███.██ |
| Norway | max AUP (pharmacy retail) | 3 | 43 | NOK███.██ |
| Greece | producer price (ex-factory) | 41 | 41 | EUR███.██ |
| Hungary | producer price (ex-factory) | 23 | 30 | HUF███.██ |
| Saudi Arabia | public | 20 | 29 | SAR███.██ |
| Luxembourg | reimbursement | 20 | 20 | EUR███.██ |
| Slovakia | categorised final price | 18 | 18 | EUR███.██ |
| South Africa | single exit price | 17 | 17 | ZAR███.██ |
| Morocco | PPV (public price) | 5 | 9 | MAD███.██ |
| Bahrain | retail (max) | 3 | 8 | BHD███.██ |
| United Arab Emirates | public | 4 | 4 | AED███.██ |
| United Kingdom | hospital | 3 | 3 | GBP███.██ |
625 pack listings across 263 brand entries and 15 price bases, refreshed 08 Sep 2026. Ranges span every Fentanyl pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Fentanyl in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
14 holders have a Canadian DIN containing Fentanyl, across 84 DINs, of which 16 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 10 | 10 | FENTORA, TEVA-FENTANYL | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 6 | 6 | SANDOZ FENTANYL PATCH | Sourceable in Canada |
| JANSSEN INC | 10 | 0 | DURAGESIC, DURAGESIC 100, DURAGESIC 12, DURAGESIC 25, DURAGESIC 50, DURAGESIC 75 | No marketed DIN |
| RANBAXY PHARMACEUTICALS CANADA INC. | 9 | 0 | RAN-FENTANYL MATRIX PATCH, RAN-FENTANYL TRANSDERMAL SYSTEM | No marketed DIN |
| COBALT PHARMACEUTICALS COMPANY | 6 | 0 | CO FENTANYL | No marketed DIN |
| PALADIN PHARMA INC. | 6 | 0 | ABSTRAL | No marketed DIN |
| APOTEX INC | 5 | 0 | APO-FENTANYL MATRIX | No marketed DIN |
| MEDA AB | 5 | 0 | ONSOLIS | No marketed DIN |
| MYLAN PHARMACEUTICALS ULC | 5 | 0 | MYLAN-FENTANYL MATRIX PATCH | No marketed DIN |
| PATRIOT A DIVISION OF JANSSEN INC | 5 | 0 | PAT-FENTANYL MAT | No marketed DIN |
| PHARMASCIENCE INC | 5 | 0 | PMS-FENTANYL MTX | No marketed DIN |
| PRO DOC LIMITEE | 5 | 0 | FENTANYL PATCH | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 400 MCG |
|---|---|
| Dosage form | TABLET (EFFERVESCENT) |
| Route | SUBLINGUAL ; BUCCAL |
| Pack configuration (monograph) | null |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Fentanyl |
|---|---|
| ATC code | N02AB03 |
| AHFS class | 28:08.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02408023 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2408023 |
| Brand name | FENTORA |
| Generic / active ingredient | FENTANYL (FENTANYL CITRATE) : 400 MCG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | NARCOTICS (CDSA I) |
| ATC code | N02AB03 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02AB |
| Current status | MARKETED |
| Status date | 22-Jul-2026 |
| Original market date | 2014-05-14 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Fentanyl in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by FRESENIUS KABI CANADA LTD, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
16 of 84 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| FENTORA | 200 MCG | TABLET (EFFERVESCENT) | TEVA CANADA LIMITED | MARKETED | 02408015 |
| FENTORA | 600 MCG | TABLET (EFFERVESCENT) | TEVA CANADA LIMITED | MARKETED | 02408031 |
| FENTORA | 800 MCG | TABLET (EFFERVESCENT) | TEVA CANADA LIMITED | MARKETED | 02408058 |
| FENTORA | 100 MCG | TABLET (EFFERVESCENT) | TEVA CANADA LIMITED | MARKETED | 02408007 |
| SANDOZ FENTANYL PATCH | 50 MCG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | 02327147 |
| SANDOZ FENTANYL PATCH | 100 MCG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | 02327163 |
| SANDOZ FENTANYL PATCH | 37 MCG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | 02327139 |
| SANDOZ FENTANYL PATCH | 12 MCG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | 02327112 |
| SANDOZ FENTANYL PATCH | 25 MCG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | 02327120 |
| SANDOZ FENTANYL PATCH | 75 MCG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | 02327155 |
2 · Same class — other molecules in ATC N02AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Fentanyl | ABSTRAL · APO-FENTANYL MATRIX · CO FENTANYL · DURAGESIC · DURAGESIC 100 · DURAGESIC 12 · DURAGESIC 25 · DURAGESIC 50 · DURAGESIC 75 · FENTANYL PATCH · FENTANYL TRANSDERMAL SYSTEM 100 · FENTANYL TRANSDERMAL SYSTEM 25 · FENTANYL TRANSDERMAL SYSTEM 50 · FENTANYL TRANSDERMAL SYSTEM 75 · FENTORA · INSTANYL · MYLAN-FENTANYL MATRIX PATCH · ONSOLIS · PAT-FENTANYL MAT · PMS-FENTANYL MTX · RAN-FENTANYL MATRIX PATCH · RAN-FENTANYL TRANSDERMAL SYSTEM · SANDOZ FENTANYL PATCH · TEVA-FENTANYL | 84 | 16 | Yes |
| Pethidine | DEMEROL · DEMEROL 10%-LIQ IM IV SC · DEMEROL 10%-LIQ IM SC 100MG/ML · DEMEROL 100 MG/ML · DEMEROL 50 MG/ML (MULTIPLE DOSE WITH METACRESOL AS PRESERVATIVE) · DEMEROL 50 MG/ML (SINGLE USE, PRESERVATIVE FREE) · DEMEROL 50MG - LIQ IM IV SC 50MG/ML · DEMEROL 50MG - LIQ IM SC 50MG/ML · DEMEROL 75 MG/ML · DEMEROL 75MG - LIQ IM IV SC 75MG/ML · MEPERIDINE HCL INJECTION 100MG/ML · MEPERIDINE HCL INJECTION 10MG/ML · MEPERIDINE HCL INJECTION 25MG/ML · MEPERIDINE HCL INJECTION 50MG/ML · MEPERIDINE HCL INJECTION 75MG/ML · MEPERIDINE HYDROCHLORIDE INJECTION USP · PETHIDINE INJECTION B.P. | 21 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N02AA | Codein, Combinations With Psycholeptics · Codeine, Combinations Excl. Psycholeptics · Hydromorphone · Morphine · Natural Opium Alkaloids · Opium · Oxycodone · Oxycodone And Naloxone | 378 | 129 |
| N02AX | Tapentadol · Tramadol | 41 | 30 |
| N02AJ | Codeine And Acetylsalicylic Acid · Codeine And Paracetamol · Hydrocodone And Ibuprofen · Oxycodone And Acetylsalicylic Acid · Oxycodone And Paracetamol · Tramadol And Paracetamol | 137 | 21 |
| N02AE | Buprenorphine | 15 | 4 |
| N02AF | Butorphanol · Nalbufine | 5 | 2 |
| N02AD | Pentazocine | 3 | 0 |
| N02AG | Opioids In Comb With Antispasmodics | 3 | 0 |
| N02AC | Dextropropoxyphene · Dextropropoxyphene, Comb Excl Psycholept | 7 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is FENTORA called?
The same molecule, Fentanyl, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Fentanyl ratiopharm | Latin | Norway, Sweden |
| Fentanyl Sandoz | Latin | Australia, Norway, Sweden |
| Matrifen | Latin | Czechia, Sweden |
| Durogesic | Latin | Bahrain, Czechia, Morocco, Norway |
| Abstral | Latin | Australia, Sweden |
| Fentanyl Lavipharm | Latin | Sweden |
| Fentanyl Orion | Latin | Sweden |
| LUNALDIN | Latin | Czechia |
| APO-Fentanyl | Latin | Australia |
| Durogesic® | Latin | Sweden |
| FENTANYL VIATRIS | Latin | Czechia |
| DOLFORIN | Latin | Czechia |
| Submena | Latin | Sweden |
| FENTANYL MYLAN | Latin | Czechia, Morocco |
| INSTANYL | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.